Enhanced delivery of nalidixic acid through human skin via acyloxymethyl ester prodrugs
Authors:
- Hans BundgaardHBHans Bundgaard
- Niels MørkNMNiels Mørk
- Annie HoelgaardAHAnnie Hoelgaard
- 1 October 1989
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 55 (2-3) , 91-97
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Glycolamide Esters as Biolabile Prodrugs of Carboxylic Acid Agents: Synthesis, Stability, Bioconversion, and Physicochemical PropertiesJournal of Pharmaceutical Sciences, 1988
- Glycolamide esters as a novel biolabile prodrug type for non-steroidal anti-inflammatory carboxylic acid drugsInternational Journal of Pharmaceutics, 1988
- Topical treatment of psoriasis with the topoisomerase inhibitors novobiocin and nalidixic acid: A pilot studyArchives of Dermatological Research, 1987
- Esters of N,N-disubstituted 2-hydroxyacetamides as a novel highly biolabile prodrug type for carboxylic acid agentsJournal of Medicinal Chemistry, 1987
- Transdermal drug delivery and cutaneous metabolismXenobiotica, 1987
- Pilocarpine Prodrugs II. Synthesis, Stability, Bioconversion, and Physicochemical Properties of Sequentially Labile Pilocarpine Acid DiestersJournal of Pharmaceutical Sciences, 1986
- Skin Structure and Metabolism: Relevance to the Design of Cutaneous TherapeuticsPharmaceutical Research, 1984
- Pro-drugs as drug delivery systems XXIII. Improved dermal delivery of 5-fluorouracil through human skin via N-acyloxymethyl pro-drug derivativesInternational Journal of Pharmaceutics, 1982
- The Skin as a Drug-Metabolizing OrganDrug Metabolism Reviews, 1978
- Percutaneous Absorption. On the Relevance of in Vitro DataJournal of Investigative Dermatology, 1975